{"paper_id":"932a2303-a683-4b6d-b25f-f1ea9a98f1c3","body_text":" Corresponding author: Anupam Thakur \nCopyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0. \nAn investigation into the age range of women having hysterectomy in district kullu an \nobservational study  \nAnupam Thakur * and Vivek Thakur \nDepartment of Obstetrics and Gynaecology, PGI, Himachal Pradesh, India. \nWorld Journal of Biology Pharmacy and Health Sciences, 2023, 13(03), 128–131 \nPublication history: Received on 05 February 2023; revised on 13 March 2023; accepted on 15 March 2023 \nArticle DOI: https://doi.org/10.30574/wjbphs.2023.13.3.0129  \nAbstract \nHysterectomy is typically performed on women in their late perimenopausal and postmenopausal years. Indications for \nhysterectomy include menorrhagia, uterine prolapse, postmenopausal haemorrhage, etc. These symptoms in turn could \nbe brought on by diseases such as endometrial cancer, fibroid uterus, adenomyosis, endometrial polyps, or even \nendometrial hyperplasia. Age-related pathologies differ from one another. Because of the negative effects of oestrogen \nloss, hysterectomies performed before the age of 40 should not include oophorectomies. Yet it's also perilous to leave \nbehind an organ that could develop cysts or cancer. Hence, it's necessary to weigh the risks and benefits. \nPostmenopausal symptoms and their effects continue to be a source of concern that requires constant monitoring and \nappropriate management because the perimenopausal age group turned out to be the most common one to have a \nhysterectomy. \nKeywords: Perimenopausal; Abdominal; Vaginal; Hysterectomies \n1. Introduction\nThe most frequent major operation on women performed outside of childbirth is a hysterectomy. Abdominal, vaginal, \nor laparoscopic procedures are frequently used for hysterectomy. Between 20% and 35% of women will have a \nhysterectomy in their lifetime? A hysterectomy is typically carried out in late perimenopausal and postmenopausal age \ngroups [1]. Menorrhagia, uterine prolapse, postmenopausal haemorrhage, etc. are a few of the reasons why a \nhysterectomy is performed. The pathologies that are causing these symptoms include endometrial cancer, adenomyosis, \nendometrial hyperplasia, endometrial polyps, and fibroid uterus. Age affects the type of pathologies that exist. In order \nto avoid leaving behind a potential organ that could later result in cysts or cancer, a hysterectomy performed around \nthe age of forty or beyond typically includes bilateral salpingo-oophorectomy. Women who have undergone surgery \nmay have postmenopausal symptoms to varying degrees after a variable amount of time. For women who underwent \nhysterectomies earlier in life, symptoms may be more severe [2]. Having said that, it is important to note that a \nhysterectomy should be done when there are incapacitating symptoms for which there is no effective medical treatment \nor when the risk of preserving the uterus is greater than the risk of its removal.  \nThis study will help in knowing the kind of hysterectomy the females had. The number of women using the resources \nfor hysterectomy in a government hospital setting in district kullu, Himachal Pradesh, in these age ranges will be \ndetermined by the women who underwent the procedure at these times[3]. The number of women with \npostmenopausal symptoms, the treatment modalities they are responding to, and even the proportion of this population \nrequiring orthopaedic support or gynaecological surgeries for vault prolapse will be known in future research when \nthese women are followed up. We were looking to assess hysterectomies [4]. \n\n\nWorld Journal of Biology Pharmacy and Health Sciences, 2023, 13(03), 128–131 \n129 \n2. Materials and Methodology \nThe study was carried out in the Himachal Pradesh area of Kullu for a period of twelve months. The prospective analysis \nof 100 consecutive hysterectomy instances served as the foundation for the current investigation. based on the applied \ninclusion and exclusion criteria. The research was conducted in accordance with the predetermined proforma.  \n2.1. Inclusion Criteria \n Individuals who have a hysterectomy for a variety of medical conditions are eligible for inclusion.  \n Patients for whom medical or conservative care had failed and for whom surgery was not contraindicated.  \n The patients who endorsed the release form. \n2.2. Exclusion Criteria \n Patients who had an obstetric hysterectomy were the first exclusion criteria.  \n Patients who refused to sign a consent form to take part in the trial.  \nAge, parity, and clinical results of patients having hysterectomies at the mentioned department were recorded. Each \ncase's whole history was recorded, then examinations of the general, abdominal, vaginal, and speculum. All patients had \nPap smears done. All patients underwent ultrasound examinations. Cases with fibroid uterus, adenomyosis, and \noccasionally fibroid with adenomyosis, thicker endometrium, adnexal disease, etc. were identified by ultrasonography. \nBefore anyone entered the research, they all provided their consent. Patients received detailed information about the \nstudy's objectives, that th ey wouldn't need any further tests, personal information, treatments, visits, or costs beyond \nwhat would be necessary for their therapy alone. Only the management data necessary for such particular instances \nwould be used by us. We also stressed that indiv iduals may withdraw from the study whenever they wanted to, and \ndoing so would not hurt them in any way or force them to pay anything.  \nTable 1 Age distribution of the sample \nAge Frequency Percentage \nLess than 40 12 12% \n41-50 43 43% \n51-60 21 21% \n61 and above 24 24% \nTotal 100 100% \n \nTable 2 Type of hysterectomy among the subjects \nHysterectomy Type Frequency Percentage \nTAH 3 3% \nVaginal Hysterectomy 25 25% \nTAH & BSC 72 72% \nTotal 100 100% \n3. Results  \nIn terms of age, there were 12 (12.0%) patients under the age of 40, 43 (43.0%) patients between the ages of 41 and 50, \n21 (21.0%) patients between the ages of 51 and 60, and 24 (24.0%) patients above the age of 60. Its worth of z is 2.8465. \n0.00438 is the value of p. At p .05. the outcome is noteworthy. The patients' average age (mean standard deviation) was \n51.0800 8.1954 years. TAH was performed on 3 (3.0%) patients, 72 (72.0%) patients underwent TAH with BSO, and 25 \n\nWorld Journal of Biology Pharmacy and Health Sciences, 2023, 13(03), 128–131 \n130 \n(25.0%) patients underwent a vaginal hysterectomy. Z is 6.6498, the value. P is less than.00001. At p .05. the outcome \nis noteworthy. \n4. Discussions \nWe discovered that 43 patients (43.0%), who were substantially older than other age groups (Z= 2.8465; p= 0.00438), \nwere between the ages of 41 and  50. The average age of the patients was 51.0800 8.1954 years. Prolapsed cases and \ncases of postmenopausal haemorrhage are those who are older than 60.  \nCases of uterovaginal prolapse underwent a vaginal hysterectomy. The scope of this page does not include  information \non clinical presentation in detail. That is a component of our entire investigation and will be covered in upcoming \npapers. The average age of the cohort, according to Saleh et al. (2012)[5], was 49.1 years, however, 107 patients \nunderwent hys terectomy alone, and 30 underwent hysterectomy along with bilateral salpingooophorectomy. A \npotentially cancer -prone organ like the ovary is left behind at the perimenopausal age when patients have a \nhysterectomy alone, with a mean age of roughly 50 years. In their study, the incidence of the abdominal route was 89% \nand the vaginal route was only 11%, therefore the higher percentage of the single hysterectomy group was not due to \nthe vaginal route. Follow-up for potential ovarian tumours in such circumstances, whether they are malignant or not, is \ncritical. The most prevalent age group (41%) was determined to be 40-49 years old by Gangardharan V et al (2016),[6]. \n72% of hysterectomies were performed vaginally, while the remaining Pervez S. N. et al. (2014),[ 7], reported the peak \nincidence (51%) in the 31 –40 year age group, which was a relatively young age for hysterectomy. In our analysis, we \ndiscovered that just 12% of women under the age of 40 had hysterectomies. Peak age incidence was determined to be \nbetween 41 and 50 years old. According to Ebinesh A. et al. [8] the age range between 41 and 50 years old was the most \ncommon for abdominal hysterectomy. According to Abdullah LS et al. [9], the patients' ages ranged from 23 to 90, with \na 49-year-old median. \n5. Conclusion \nThe age group going through a hysterectomy most frequently turned out to be postmenopausal. In this age group, a \nhysterectomy may result in postmenopausal symptoms and consequences. Therefore, it is essential from both the \npatient's and the surg eon's viewpoints to receive thorough counselling prior to the procedure. If different treatment \napproaches are adequate for the instance concerned, that is to be sought after. If surgery is the sole option, risk against \nbenefit should be considered, and ch oices should be tailored to the person. If a hysterectomy is performed, it will be \ndifficult to minimise the physical and psychological morbidity, especially for women who are having oophorectomy \nduring pre- and perimenopausal age.  \nCompliance with ethical standards \nAcknowledgments \nThe authors acknowledge the support provided by the staff and the patients of the hospital in Kullu.  \nDisclosure of conflict of interest \nNone  \nStatement of informed consent  \nInformed consent was obtained from all individual participants included in the study. \nReferences \n[1] Farquhar CM, Sadler L, Harvey SA, Stewart AW. The association of hysterectomy and menopause: a prospective \ncohort study. BJOG: An International Journal of Obstetrics & Gynaecology. 2005 Jul;112(7):956 -62. \n[2] Hickey M, Ambekar M, Hammond I. Should the ovaries be removed or retained at the time of hysterectomy for \nbenign disease?. Human reproduction update. 2010 Mar 1;16(2):131-41. \n[3] Prusty RK, Choithani C, Gupta SD. Predictors of hysterectomy among married women 15 –49 years in India. \nReproductive health. 2018 Dec;15:1-1. \n\nWorld Journal of Biology Pharmacy and Health Sciences, 2023, 13(03), 128–131 \n131 \n[4] Moorman PG, Myers ER, Schildkraut JM, Iversen ES, Wang F, Warren N. Effect of hysterectomy with ovarian \npreservation on ovarian function. Obstetrics and gynecology. 2011 Dec;118(6):1271.  \n[5] Saleh SS, Fra m K. Histopathology diagnosis in women who underwent a hysterectomy for a benign condition. \nArchives of Gynecology and Obstetrics 2012;285(5):1339-43 \n[6] Gangadharan V, Prasanthi C. Hysterectomy - a clinicopathological correlation in a rural setting. Indian J Basic \nAppl Med Res 2016;5:8-15. \n[7] Pervez SN, Javed K, Obald M. Hysterectomy: a clinicopathological correlation. KJMS 2014;7(2):295 -7.  \n[8] Ebinesh A, Sharada MS, Krishna MC. Clinico-pathological correlation of abdominal hysterectomy specimens. Int J \nSci & Res 2015;4(6):1084-9. \n[9] Abdullah LS. Hysterectomy: a clinicopathologic correlation. Bahrain Medical Bulletin 2006;28(2):1 -6","source_license":"CC0","license_restricted":false}